CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 7 enrolled
Drug / intervention
Cryo Spray Ablation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00754468
NCT00754468Phase 4Completed
CompareCT.gov

A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)

CSA Medical, Inc.·interventional·Posted Sep 18, 2008·Updated Nov 4, 2015

In Brief

A Phase 4 clinical trial evaluating Cryo Spray Ablation for Barrett's Esophagus and Esophageal Cancer. Completed, enrolled 7 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical resection specimens from subjects undergoing esophagectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBarrett's Esophagus, Esophageal Cancer
CountriesUnited States
CollaboratorsUniversity of Miami

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 18, 2008
Enrollment StartFeb 1, 2009
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 17.8 years ago

Interventions

Cryo Spray Ablationdevice

Cryo Spray Ablation 4 cycles x 10 seconds treatment

Cryo Spray Ablationdevice

Cryo Spray Ablation 2 cycles x 20 seconds